GlaxoSmithKline plc (LON:GSK) price target set to GBX 1,900 by Goldman Sachs Group

0

Analyst Ratings For GlaxoSmithKline plc (LON:GSK)

Today, Goldman Sachs Group set its price target on GlaxoSmithKline plc (LON:GSK) to GBX 1,900 per share.

There are 10 Hold Ratings, 8 Buy Ratings, 2 Sell Ratings, no Strong Buy Ratings on the stock.

The current consensus rating on GlaxoSmithKline plc (LON:GSK) is Hold with a consensus target price of GBX 1,530.34 per share, a potential .

Some recent analyst ratings include

  • 12/19/2018-GlaxoSmithKline plc (LON:GSK) had its Buy rating reiterated by Shore Capital
  • 12/19/2018-GlaxoSmithKline plc (LON:GSK) had its Hold rating reiterated by Liberum Capital with a GBX 1,700 price target

    Recent Trading Activity for GlaxoSmithKline plc (LON:GSK)
    Shares of GlaxoSmithKline plc closed the previous trading session at 491,20 −15,80 1,05 % with 313063 shares trading hands.